WallStreetZenWallStreetZen

NASDAQ: BPMC
Blueprint Medicines Corp Stock Forecast, Predictions & Price Target

Analyst price target for BPMC

Based on 10 analysts offering 12 month price targets for Blueprint Medicines Corp.
Min Forecast
$63.00-28.72%
Avg Forecast
$89.10+0.81%
Max Forecast
$115.00+30.12%

Should I buy or sell BPMC stock?

Based on 10 analysts offering ratings for Blueprint Medicines Corp.
Buy
Strong Buy
3 analysts 30%
Buy
4 analysts 40%
Hold
2 analysts 20%
Sell
0 analysts 0%
Strong Sell
1 analysts 10%

Be the first to know when Wall Street analysts revise their BPMC stock forecasts and price targets.

BPMC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-02-26
lockedlocked$00.00+00.00%2024-02-16
lockedlocked$00.00+00.00%2024-02-13
lockedlocked$00.00+00.00%2024-01-09
Raymond James
Bottom 5%
5
Strong BuyMaintains$100.00+13.15%2023-12-22
Wells Fargo
Top 2%
99
Strong BuyMaintains$115.00+30.12%2023-12-19
HC Wainwright & Co.
Top 3%
98
BuyReiterates$85.00-3.82%2023-12-11
Oppenheimer
Bottom 13%
13
BuyUpgrades$85.00-3.82%2023-10-27
Morgan Stanley
Top 6%
95
HoldMaintains$63.00-28.72%2023-10-27

1 of 1

Forecast return on equity

Is BPMC forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is BPMC forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

BPMC revenue forecast

What is BPMC's revenue in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$392.3M+57.3%
Avg 2 year Forecast
$563.2M+125.82%
Avg 3 year Forecast
$753.6M+202.19%
BPMC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BPMC revenue growth forecast

How is BPMC forecast to perform vs Biotechnology companies and vs the US market?
Company
44.37%
Industry
38.32%
Market
10.27%
BPMC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BPMC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BPMC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BPMC$88.38$89.10+0.81%Buy
APLS$48.03$78.86+64.18%Strong Buy
IONS$40.91$56.78+38.79%Buy
HALO$38.02$54.17+42.47%Buy
KRYS$169.64$182.80+7.76%Strong Buy

Blueprint Medicines Stock Forecast FAQ

Is Blueprint Medicines Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: BPMC) stock is to Buy BPMC stock.

Out of 10 analysts, 3 (30%) are recommending BPMC as a Strong Buy, 4 (40%) are recommending BPMC as a Buy, 2 (20%) are recommending BPMC as a Hold, 0 (0%) are recommending BPMC as a Sell, and 1 (10%) are recommending BPMC as a Strong Sell.

If you're new to stock investing, here's how to buy Blueprint Medicines stock.

What is BPMC's revenue growth forecast for 2024-2026?

(NASDAQ: BPMC) Blueprint Medicines's forecast annual revenue growth rate of 44.37% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Blueprint Medicines's revenue in 2024 is $249,380,000.On average, 9 Wall Street analysts forecast BPMC's revenue for 2024 to be $24,020,266,699, with the lowest BPMC revenue forecast at $22,763,718,733, and the highest BPMC revenue forecast at $25,999,233,306. On average, 9 Wall Street analysts forecast BPMC's revenue for 2025 to be $34,483,090,520, with the lowest BPMC revenue forecast at $30,862,914,657, and the highest BPMC revenue forecast at $37,853,806,005.

In 2026, BPMC is forecast to generate $46,144,720,251 in revenue, with the lowest revenue forecast at $37,496,209,391 and the highest revenue forecast at $54,239,568,683.

What is BPMC's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BPMC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is BPMC's Price Target?

According to 10 Wall Street analysts that have issued a 1 year BPMC price target, the average BPMC price target is $89.10, with the highest BPMC stock price forecast at $115.00 and the lowest BPMC stock price forecast at $63.00.

On average, Wall Street analysts predict that Blueprint Medicines's share price could reach $89.10 by Apr 10, 2025. The average Blueprint Medicines stock price prediction forecasts a potential upside of 0.81% from the current BPMC share price of $88.38.

What is BPMC's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BPMC) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.